TheracosBio, LLC

2 FDA products 1 active ingredients HUMAN PRESCRIPTION DRUG

TheracosBio, LLC is listed as the manufacturer on 2 FDA drug label records covering 1 distinct active ingredients predominantly human prescription drug products.

About TheracosBio, LLC

TheracosBio, LLC is named as the labeler on 2 FDA drug label records. Its catalogue spans 1 distinct active ingredients, led by BEXAGLIFLOZIN. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: improve glycemic, type diabetes, indicated adjunct, control adults, mellitus limitations, see warnings, sodium-glucose co-transporter, sglt inhibitor. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.

Active ingredients in this portfolio

Active ingredientProducts
BEXAGLIFLOZIN 2

Dosage forms and routes

Dosage formProductsRouteProducts
— — ORAL 2
— — — —
— — — —
— — — —
— — — —
— — — —

FDA drug products from TheracosBio, LLC

Brand nameGenericTypeRoute
BRENZAVVY BEXAGLIFLOZIN HUMAN PRESCRIPTION DRUG ORAL
Bexagliflozin BEXAGLIFLOZIN HUMAN PRESCRIPTION DRUG ORAL

Frequently asked questions

How many FDA drug products does TheracosBio, LLC make?
2 FDA drug label records name TheracosBio, LLC as the manufacturer, covering 1 distinct active ingredients.

What active ingredients does TheracosBio, LLC produce?
The most frequent active ingredients in this portfolio are BEXAGLIFLOZIN.

Are TheracosBio, LLC products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.

Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.

Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.